Know more about all the european and international projects in which the Park participates.
Mental Health and Emotional Well-Being
Devicare, a company located in the UAB Research Park, and nine leading hospitals in urology have started the pioneering international "Double J" study to evaluate the combined use of a medical device and a nutraceutical in controlling urinary pH.
Smart-4-Fabry is a project funded by the European Commission within the Horizon 2020 Research and Innovation program with € 5.8 M for 4 years, which aims to develop a new nanomedicine for the treatment of the Fabry rare disease.
The biopharmaceutical company, Ability Pharmaceuticals, a member of the UAB Research Park, has announced that the United States Food and Drug Administration (FDA) has approved a phase 1/2 study to assess the efficacy and safety of ABTL0812.
The UAB Research Park has brought over 80 people in the presentation of the Bioindustrial Community for Bioeconomics (BBCAT), a proposal to promote innovative projects which can improve the efficiency, competitiveness and sustainability of bioproductive processes.
